# Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation

> **NCT03851211** · — · UNKNOWN · sponsor: **The Leeds Teaching Hospitals NHS Trust** · enrollment: 100 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03851211
- **Lead sponsor:** The Leeds Teaching Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-21
- **Primary completion:** 2020-10-30
- **Final completion:** 2020-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2019-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851211, "Prolaris Enhanced Risk Stratification - an ecONomic and clinicAL Evaluation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03851211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*